Healthcare products company CCA Industries Inc (OTC:CAWW) disclosed on Monday that its income amounted to USD349,320 for the second quarter ended 31 May 2019.
This marks an improvement when compared with a loss of USD292,320 for the same period in fiscal 2018.
Revenues of USD5.458m were generated for the three months ended 31 May 2019,up over revenues of USD4.225m for the comparable period in fiscal 2018.
EBITDA of USD574,176 were recorded for the second quarter ended 31 May 2019, a rise from EBITDA of USD231,136 for the corresponding period in fiscal 2018.
Heron Therapeutics announces tax benefits preservation plan adoption
Essa Pharma sets ex-dividend date and due bill trading for USD80m capital return
BioDlink's bevacizumab injection secures Colombia and Pakistan marketing authorisation
GSK to receive USD370m and future royalties in CureVac/BioNTech settlement